Disruptions in the development of cell and gene therapies

被引：4

|

作者：

Yang, Guang ^{[1
]}

Liu, Ling ^{[2
]}

Suhendra, Michelle ^{[3
]}

Agarwal, Stuti ^{[2
]}

Smith, Jeffrey F. ^{[4
]}

机构：

[1] McKinsey & Co Inc, Charlotte, NC USA

[2] McKinsey & Co Inc, Summit, NJ USA

[3] McKinsey & Co Inc, Waltham, MA USA

[4] McKinsey & Co Inc, Boston, MA 02115 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2022年 / 21卷 / 03期

关键词：

D O I：

10.1038/d41573-022-00004-6

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：171 / 171

页数：1

相关论文

共 50 条

[41] Strategy Escalation: An emerging paradigm for safe clinical development of T cell gene therapies
Richard Paul Junghans
Journal of Translational Medicine, 8
[42] Strategy Escalation: An emerging paradigm for safe clinical development of T cell gene therapies
Junghans, Richard Paul
JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8
[43] Gene therapies need new development models
Fulvio Mavilio
Nature, 2012, 490 : 7 - 7
[44] Adenosine augmentation therapies (AATs) for epilepsy: Prospect of cell and gene therapies
Boison, Detlev
EPILEPSY RESEARCH, 2009, 85 (2-3) : 131 - 141
[45] Accelerating the development of personalized DMD gene therapies
Rok, M.
Ivakine, E.
Cohn, R.
NEUROMUSCULAR DISORDERS, 2020, 30 : S130 - S130
[46] Gene therapies need new development models
Mavilio, Fulvio
NATURE, 2012, 490 (7418) : 7 - 7
[47] FDA Policies Address Development of Gene Therapies
Voelker, Rebecca
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (09): : 817 - 817
[48] Development of gene therapies—lessons from nusinersen
L Xu
I Irony
W W Bryan
B Dunn
Gene Therapy, 2017, 24 : 527 - 528
[49] Global development of cell therapies - Is it possible?
Frey-Vasconcells, J. L.
CYTOTHERAPY, 2006, 8
[50] ADVANCED MATERIALS AND THE DEVELOPMENT OF CELL THERAPIES
Simula, T.
CYTOTHERAPY, 2016, 18 (06) : S86 - S86

← 1 2 3 4 5 →